Collaborative Advocacy Responds to Swift Federal and State Policy Shifts
WASHINGTON, May 8, 2025 /PRNewswire/ — Access Ready Strategic, a national cross-disability education and advocacy organization, has joined The Consortium for Constituents with Disabilities (CCD), The National Association of Councils on Developmental Disabilities (NACDD), and other leading disability rights organizations to issue strong policy positions in response to recent proposed changes at federal and state levels.
In an increasingly rapid policy-making environment, impacted communities are responding through united fronts formed by their representative organizations. These joint efforts reinforce the civil rights and inclusion of people with disabilities across the United States.
Among the recent policy actions and organizational responses:
Access Ready Strategic Social Purpose Corporation is a cross-disability, independent education and advocacy organization dedicated to promoting civil rights and digital inclusion. With a focus on ensuring accessibility across all information and communications technology (ICT), Access Ready supports public and private sectors in creating systems that foster independence, self-sufficiency, and civic participation for people with disabilities.
As ICT becomes ever more vital to commerce, governance, and public services, ensuring it is accessible is not only a matter of equity—it is a matter of civil rights.
Access Ready Strategic proudly supports the policy stances of its partner organizations and encourages others to review these statements in full at: https://accessreadystrategic.com/access-ready-in-support-of-policies-and-positions/
Media Contact:
Douglas George Towne
Chair and Chief Executive Officer
Access Ready Strategic
394882@email4pr.com
(727) 452-8132
(727) 531-1000
https://accessreadystrategic.com
Press Resources
SOURCE Access Ready Inc.
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance…
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…